The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Search for "Sarilumab"

Search results for: Sarilumab

Rheumatology Drug Updates: Biosimilars Seek Regulatory Approval in the U.S., Europe; Methotrexate Underused

February 16, 2016 • By Michele B. Kaufman, PharmD, BCGP

Biosimilars Receive Positive News On Nov. 19, 2015, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended granting marketing authorization for SB4, an etanercept biosimilar product that will be called Benepali.1 If approved, Benepali can be used to treat rheumatoid arthritis (RA), psoriatic arthritis (PsA), axial spondyloarthritis and plaque psoriasis…. [Read More]

Filed Under: Biologics & Biosimilars, DMARDs & Immunosuppressives, Drug Updates Tagged With: Approvals, Biosimilars, drug, FDA, Ibuprofen, Methotrexate, pregabalin, Rheumatoid arthritis, rheumatology, Safety, sarilumab

Biosimilar Drugs for RA Studied in Multiple Trials

August 17, 2015 • By Michele B. Kaufman, PharmD, BCGP

Etanercept Biosimilars A number of Phase 3 trials are ongoing for etanercept biosimilars.1 One evaluation identified three trials in rheumatoid arthritis (RA) patients and one in psoriasis patients. The psoriatic arthritis trial evaluated PASI as a primary endpoint and the following secondary endpoints: PASI50, PASI75, PASI90, PASI score, laboratory values, ECG, adverse events (AEs), injection… [Read More]

Filed Under: Biologics & Biosimilars, Conditions, Drug Updates, Rheumatoid Arthritis Tagged With: biosimilar, clinical trial, Drugs, outcome, Rheumatoid arthritis, rheumatology, Safety

Biosimilars for RA Studied in Multiple Trials

June 17, 2015 • By Michele B. Kaufman, PharmD, BCGP

Biosimilars for etanercept and sarilumab are being examined in multiple Phase 3 trials for their effects in RA and psoriasis patients.... [Read More]

Filed Under: Biologics & Biosimilars, Conditions, Drug Updates, Rheumatoid Arthritis Tagged With: Biosimilars, clinical trials, Psoriatic Arthritis

EULAR 2014: Non-Tumor Necrosis Factor Biologics Update

August 1, 2014 • By Thomas R. Collins

Clinical trials on rheumatology drugs, including sarilumab, show promise for patients with rheumatoid arthritis also taking methotrexate... [Read More]

Filed Under: Biologics & Biosimilars, Conditions, Drug Updates, Rheumatoid Arthritis Tagged With: Biologics, Collins, EULAR, itolizumab, Methotrexate, Rheumatoid arthritis, rheumatologist, rheumatology, rituximab, sarilumab

EULAR 2014: Research on Rheumatoid Arthritis, Spondyloarthritis

August 1, 2014 • By Thomas R. Collins

Latest findings on rheumatological drug therapies, including methotrexate for RA, tumor necrosis factor inhibitors for SpA... [Read More]

Filed Under: Biologics & Biosimilars, Conditions, DMARDs & Immunosuppressives, Drug Updates, Rheumatoid Arthritis, Safety, Spondyloarthritis Tagged With: Ankylosing Spondylitis, anti­inflammatory, Biologics, Collins, drug, EULAR, Glucocorticoids, infliximab, International, Methotrexate, Research, Rheumatoid arthritis, rheumatology, Safety

Rheumatology Drug Updates

January 1, 2014 • By Michele B. Kaufman, PharmD, BCGP

Information on new approvals and medication safety that rheumatologists need to know... [Read More]

Filed Under: Biologics & Biosimilars, Conditions, DMARDs & Immunosuppressives, Drug Updates, Rheumatoid Arthritis, Safety, Spondyloarthritis Tagged With: Ankylosing Spondylitis, antiinflammatory, Approval, axial spondyloarthritis (SpA), Biologics, drug, FDA, Methotrexate, Research, Rheumatoid arthritis, rheumatologist, rheumatology, Safety, tocilizumab

Information on New Drug Approvals and Medication Safety

March 8, 2012 • By Michele B. Kaufman, PharmD, BCGP

Rheumatology-related drug safety, approvals, and what’s in the pipeline.... [Read More]

Filed Under: Biologics & Biosimilars, DMARDs & Immunosuppressives, Drug Updates, Safety Tagged With: antiinflammatory, Biologics, crystal arthritis, drug, Gout, JAK inhibitors, janus kinase, Methotrexate, Rheumatoid arthritis, rheumatologist, Safety, Tofacitinib

Drug Updates: Apremilast, Belimumab, and More

January 13, 2012 • By Michele B. Kaufman, PharmD, BCGP

Information on new approvals and medication safety... [Read More]

Filed Under: Biologics & Biosimilars, Conditions, DMARDs & Immunosuppressives, Drug Updates, Safety, SLE (Lupus), Spondyloarthritis Tagged With: Ankylosing Spondylitis, antiinflammatory, Approvals, Biologics, drug, JAK inhibitors, janus kinase, Methotrexate, Pipeline, Psoriatic Arthritis, Safety, Systemic lupus erythematosus

  • « Previous Page
  • 1
  • 2
  • 3
  • 4

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)